Active Ingredient(s):Stiripentol FDA Approved: * August 20, 2018 Pharm Company: *BIOCODEX SA Category:Anticonvulsant
Stiripentol, sold under the brand name Diacomit, is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder.
The most common side effects include loss of appetite, weight loss, insomnia (difficulty sleeping), drowsiness, ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength) and dystonia (muscle disorders).
1 Medical uses
* May have multiple approval dates, manufacturers, or labelers.